misonidazole has been researched along with Cancer of Mouth in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fujima, N; Hirata, K; Kudo, K; Minowa, K; Shima, T; Yamano, S | 1 |
| Asaka, T; Hirata, K; Kitagawa, Y; Kuge, Y; Ohga, N; Okamoto, S; Sato, J; Shiga, T; Shindoh, M; Tamaki, N; Watanabe, S | 1 |
| Asaka, T; Hirata, K; Kitagawa, Y; Ohga, N; Sato, J; Satoh, A; Shiga, T; Tamaki, N; Watanabe, S | 1 |
| Hata, H; Kitagawa, Y; Kuge, Y; Okamoto, S; Sato, J; Shiga, T; Shindoh, M; Tamaki, N; Yamazaki, Y | 1 |
| Asaka, T; Hata, H; Kitagawa, Y; Kuge, Y; Miyakoshi, M; Okamoto, S; Sato, J; Shiga, T; Shindoh, M; Tamaki, N; Yamazaki, Y | 1 |
| Katoh, N; Kuge, Y; Okamoto, S; Onimaru, R; Shiga, T; Shirato, H; Suzuki, R; Takeuchi, W; Tamaki, N; Tsuchiya, K; Yasuda, K | 1 |
| Byhardt, RW; Cox, JD; Greenberg, M; Komaki, R | 1 |
| Dar'ialova, SL; Kiseleva, ES | 1 |
| Creasey, WA; Thrall, DE | 1 |
| Fazekas, JT; Goodman, RL; McLean, CJ | 1 |
| Barry, L; Blekkenhorst, G; Cridland, S; Rombouts, T; Sealy, R | 1 |
| Denekamp, J; Hermeking, H; Kummermehr, J; Lindenberger, J | 1 |
1 review(s) available for misonidazole and Cancer of Mouth
| Article | Year |
|---|---|
[Electron acceptor compounds as radiation sensitizers of hypoxic cells in human tumors].
Topics: Brain Neoplasms; Combined Modality Therapy; Esophageal Neoplasms; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Metronidazole; Misonidazole; Mouth Neoplasms; Neoplasms; Radiation-Sensitizing Agents; Rectal Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms | 1984 |
11 other study(ies) available for misonidazole and Cancer of Mouth
| Article | Year |
|---|---|
Evaluation of non-Gaussian model-based diffusion-weighted imaging in oral squamous cell carcinoma: comparison with tumour functional information derived from positron-emission tomography.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diffusion Magnetic Resonance Imaging; Female; Humans; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2020 |
Topics: Adult; Aged, 80 and over; Carcinoma, Squamous Cell; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tumor Hypoxia | 2017 |
Hypoxic volume evaluated by
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Neck Dissection; Neoplasm Grading; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Treatment Outcome; Tumor Hypoxia | 2018 |
18F-fluoromisonidazole PET uptake is correlated with hypoxia-inducible factor-1α expression in oral squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cell Hypoxia; Female; Humans; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2013 |
Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Positron-Emission Tomography; Preoperative Period; Treatment Outcome | 2014 |
[18F]fluoromisonidazole and a new PET system with semiconductor detectors and a depth of interaction system for intensity modulated radiation therapy for nasopharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Case-Control Studies; Cell Hypoxia; Female; Humans; Laryngeal Neoplasms; Lutetium; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Multimodal Imaging; Nasopharyngeal Neoplasms; Nasopharynx; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Semiconductors; Silicates; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Reduced fractionation and the potential of hypoxic cell sensitizers in irradiation of malignant epithelial tumors.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Humans; Lung Neoplasms; Misonidazole; Mouth Neoplasms; Nitroimidazoles; Oropharynx; Pharyngeal Neoplasms; Radiation-Sensitizing Agents; Radiotherapy Dosage; Retrospective Studies | 1980 |
Pharmacokinetic and anti-tumor studies with the radiosensitizer misonidazole in dogs with spontaneous fibrosarcomas.
Topics: Animals; Dog Diseases; Dogs; Fibrosarcoma; Mandibular Neoplasms; Maxillary Neoplasms; Misonidazole; Mouth Neoplasms; Nitroimidazoles; Palate, Soft | 1982 |
The value of adjuvant misonidazole in the definitive irradiation of advanced head and neck squamous cancer: an RTOG pilot study (#78-02).
Topics: Aged; Carcinoma, Squamous Cell; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Nausea; Neoplasm Recurrence, Local; Neoplasm Staging; Nitroimidazoles; Paresthesia; Pharyngeal Neoplasms; Prognosis | 1981 |
Interstitial misonidazole: clinical experience in advanced mouth cancer.
Topics: Animals; Carcinoma, Squamous Cell; Drug Implants; Humans; Misonidazole; Mouth Neoplasms; Needles; Neoplasm Recurrence, Local; Swine | 1988 |
Response of human tumour xenografts to fractionated X-irradiation.
Topics: Animals; Carcinoma; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease Models, Animal; Dose-Response Relationship, Radiation; Female; Humans; Male; Mice; Mice, Nude; Misonidazole; Mouth Neoplasms; Neoplasm Transplantation; Photochemotherapy; Radiotherapy Dosage; Tonsillar Neoplasms; Transplantation, Heterologous | 1986 |